These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9046489)

  • 1. Prolonged myocardial contrast echocardiography via peripheral venous administration of QW3600 injection (EchoGen): its efficacy and side effects.
    Beppu S; Matsuda H; Shishido T; Matsumura M; Miyatake K
    J Am Soc Echocardiogr; 1997; 10(1):11-24. PubMed ID: 9046489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
    Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
    J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety and efficiency of Echogen. Transthoracic echocardiography study].
    Espinola-Zavaleta N; Yánac-Chávez P; Vargas-Barrón J; Romero-Cárdenas A; Roldán-Gómez J
    Gac Med Mex; 2001; 137(3):203-8. PubMed ID: 11432089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent opacification of the left ventricle and myocardium with a new echo contrast agent.
    Strauss AL; Beller KD
    Ultrasound Med Biol; 1999 Jun; 25(5):763-9. PubMed ID: 10414894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavity.
    Leischik R; Beller KD; Erbel R
    Basic Res Cardiol; 1996; 91(1):101-9. PubMed ID: 8660247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of QW7437, a new fluorocarbon-based echocardiographic contrast agent.
    Main ML; Escobar JF; Hall SA; Grayburn PA
    J Am Soc Echocardiogr; 1997 Oct; 10(8):798-804. PubMed ID: 9356943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
    Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
    J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and adverse effects of transpulmonary contrast echocardiography using sonicated albumin.
    Nakatani S; Beppu S; Ohta T; Matsuda H; Miyatake K
    Intern Med; 1994 Apr; 33(4):204-9. PubMed ID: 8069014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia.
    Grayburn PA; Erickson JM; Escobar J; Womack L; Velasco CE
    J Am Coll Cardiol; 1995 Nov; 26(5):1340-7. PubMed ID: 7594052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous perfluoropropane-exposed sonicated dextrose albumin produces myocardial ultrasound contrast that correlates with coronary blood flow.
    Porter TR; Xie F; Kilzer K
    J Am Soc Echocardiogr; 1995; 8(5 Pt 1):710-8. PubMed ID: 9417215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of risk-area myocardium as a high-intensity, hyperenhanced "hot spot" by myocardial contrast echocardiography following coronary reperfusion: quantitative analysis.
    Kunichika H; Peters B; Cotter B; Masugata H; Kunichika N; Wolf PL; DeMaria AN
    J Am Coll Cardiol; 2003 Aug; 42(3):552-7. PubMed ID: 12906988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polymer microparticles for right and left heart echocardiography and imaging myocardial perfusion after peripheral vein injection].
    Zotz R; Genth S; Grande J; Walch A; Ziehn P; Krone V; Schuler G
    Z Kardiol; 1996 Dec; 85(12):924-31. PubMed ID: 9082670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of perfusion defects during coronary occlusion and myocardial reperfusion after thrombolysis by intravenous administration of the echo-enhancing agent BR1.
    Rovai D; Lubrano V; Vassalle C; Paterni M; Marini C; Kozakova M; Castellari M; Taddei L; Trivella MG; Distante A; DeMaria AN; L'Abbate A
    J Am Soc Echocardiogr; 1998 Feb; 11(2):169-80. PubMed ID: 9517556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myocardial contrast echocardiography from peripheral venous injection: the potential for detection of myocardial perfusion abnormality].
    Matsumura M
    Nihon Rinsho; 1998 Apr; 56(4):914-20. PubMed ID: 9577608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
    Grayburn PA; Weiss JL; Hack TC; Klodas E; Raichlen JS; Vannan MA; Klein AL; Kitzman DW; Chrysant SG; Cohen JL; Abrahamson D; Foster E; Perez JE; Aurigemma GP; Panza JA; Picard MH; Byrd BF; Segar DS; Jacobson SA; Sahn DJ; DeMaria AN
    J Am Coll Cardiol; 1998 Jul; 32(1):230-6. PubMed ID: 9669275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of myocardial postreperfusion viability by intravenous myocardial contrast echocardiography: analysis of the intensity and texture of opacification.
    Ohmori K; Cotter B; Leistad E; Bhargava V; Wolf PL; Mizushige K; DeMaria AN
    Circulation; 2001 Apr; 103(15):2021-7. PubMed ID: 11306533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography.
    Grayburn P
    Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I12-8. PubMed ID: 9383597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of clinically significant increase in pulmonary artery pressure after intravenous perflutren injection for myocardial perfusion imaging in pigs.
    de Chantal M; Amyot R; Diodati JG; LeBlanc AR; Pharand C
    J Am Soc Echocardiogr; 2005 Dec; 18(12):1299-303. PubMed ID: 16376758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent.
    Meza M; Greener Y; Hunt R; Perry B; Revall S; Barbee W; Murgo JP; Cheirif J
    Am Heart J; 1996 Oct; 132(4):871-81. PubMed ID: 8831379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contrast echocardiography of the left heart by intravenous injection of perfluorochemical emulsion].
    Matsuda M; Kuwako K; Sugishita Y; Ito I; Akatsuka T
    J Cardiogr; 1983 Dec; 13(4):1021-8. PubMed ID: 6678942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.